Search Login Register

Diffuse Cutaneous Leishmaniasis Summary

Description: A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.

Also Known As: Leishmaniasis, Diffuse Cutaneous; Cutaneous Leishmaniases, Diffuse; Cutaneous Leishmaniasis, Diffuse; Diffuse Cutaneous Leishmaniases; Leishmaniases, Diffuse Cutaneous

Networked: 57 relevant articles (3 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Diffuse Cutaneous Leishmaniasis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tamoxifen : 1 outcome in 1 result : FDA 12 Generic
  2. Antigens : 1 study in 20 results : IBA
  3. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1) : 1 study in 1 result : IBA
  4. HLA-DR Antigens (HLA-DR) : 1 study in 1 result : IBA
  5. miltefosine : 6 results : IBA
  6. Antibodies : 5 results : IBA
  7. Cytokines : 3 results : IBA
  8. Pentamidine (NebuPent) : 3 results : FDA 6 Generic
  9. Carbon Monoxide : 3 results : IBA
  10. Interleukin-10 (Interleukin 10) : 2 results : IBA
Show All >>

Diseases Related to Diffuse Cutaneous Leishmaniasis

  1. Cutaneous Leishmaniasis
  2. Leishmaniasis
  3. Lepromatous Leprosy
  4. Visceral Leishmaniasis (Kala Azar)
  5. Mucocutaneous Leishmaniasis
Show All >>

Key Therapies for Diffuse Cutaneous Leishmaniasis

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 2 outcomes in 4 results
  2. Immunotherapy : 1 outcome in 2 results

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.